Meta-analyses determined the proportion of people meeting physical activity guidelines and recommendations of (1) >150 min per week of moderate to vigorous physical activity (MVPA) in bouts of >10 min; (2) >150 min per week of MVPA in absence of bouts; (3) >10,000 steps per day and >7000 steps per day. The Grades of Research, Assessment, Development and Evaluation (GRADE) approach was used to determine the quality of the evidence.

Results:

For knee osteoarthritis, 21 studies involving 3266 participants averaged 50 min per week (95% CI = 46, 55) of MVPA when measured in bouts of >10 min, 131 min per week (95% C = 125, 137) of MVPA, and 7753 daily steps (95% CI = 7582, 7924). Proportion meta-analyses provided high quality Selisistat datasheet evidence that 13% (95% CI = 7, 20) completed >150 min per week

of MVPA in bouts of >10 min, low quality evidence that 41% (95% CI = 23, 61) completed >150 min per week of MVPA in absence of bouts, moderate quality evidence that 19% CYT387 JAK/STAT inhibitor (95% CI = 8, 33) completed >10,000 steps per day, and low quality evidence that 48% (95% CI = 31, 65) completed >7000 steps per day.

For hip osteoarthritis, 11 studies involving 325 participants averaged 160 min per week (95% CI = 114, 216) of MVPA when measured in bouts of >10 min, 189 min per week (95% CI = 166, 212) of MVPA, and 8174 daily steps (95% CI = 7670, 8678). Proportion meta-analyses provided low quality evidence that 58% (95% CI = 18, 92) completed >150 min per week of MVPA in absence of bouts, low quality evidence that 30% (95% CI = 13, 50) completed >10,000 steps per day, and low quality evidence that 60% (95% CI = 47, 73) completed >7000 steps per day.

Conclusion: A small to moderate proportion

of people with knee and hip osteoarthritis met physical activity guidelines and recommended daily steps. Future research should establish the effects of increasing physical activity in this population to meet the current physical activity guidelines. (C) 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.”
“We provide preliminary psychometric results concerning the use of a modified https://www.selleckchem.com/products/mi-503.html FAMCARE scale, adapted for patient use, to assess satisfaction with outpatient care in advanced stage cancer patients.

Participants were 145 outpatients with advanced cancer who were participating in a phase II trial of an outpatient palliative care intervention. Patients completed our modified FAMCARE measure of patient satisfaction and the Edmonton Symptom Assessment Scale, a measure of symptom burden. Individuals were also assessed for performance status using the Eastern Cooperative Oncology Group scale. We conducted an exploratory factor analysis of the patient satisfaction measure and performed correlations of satisfaction with symptom burden as well as with performance status.